Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: Outcomes and complications

Annals of Oncology

Volumn 24, Issue 7, 2013, Pages 1873-1879

  Raad Prof , I I ^a   Chaftari, A M ^a   Al Shuaibi, M M ^a   Jiang, Y ^a   Shomali, W ^a   Cortes, J E ^a   Lichtiger, B ^b   Hachem, R Y ^a  

^a Infectious Diseases and Employee Health ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aspergillosis; Granulocyte transfusions; Hematologic malignancy

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ECHINOCANDIN; PYRROLE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; DYSPNEA; FEMALE; FEVER; GRANULOCYTE TRANSFUSION; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG ASPERGILLOSIS; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD;

ASPERGILLOSIS; GRANULOCYTE TRANSFUSIONS; HEMATOLOGIC MALIGNANCY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CELL TRANSPLANTATION; CHILD; FEMALE; GRANULOCYTES; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPENIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883760516     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt110     Document Type: Article

References (39)

1. Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100(13): 4358-4366.
2. Ramos ER, Jiang Y, Hachem R et al. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 2011; 16(7): 1049-1060.
3. Alavi JB, Root RK, Djerassi I et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977; 296(13): 706-711.
4. Wright DG, Robichaud KJ, Pizzo PA et al. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304(20): 1185-1189.
5. Dutcher JP, Kendall J, Norris D et al. Granulocyte transfusion therapy and amphotericin B: adverse reactions? Am J Hematol 1989; 31(2): 102-108.
6. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993; 81(7): 1675-1678.
7. Caspar CB, Seger RA, Burger J et al. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colonystimulating factor. Blood 1993; 81(11): 2866-2871.
8. Ofran Y, Avivi I, Oliven A et al. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang 2007; 93(4): 363-369.
9. Sachs UJ, Reiter A, Walter T et al. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006; 46(11): 1909-1914.
10. Al-Tanbal H, Al Humaidan H, Al-Nounou R et al. The value and practicality of granulocyte transfusion: a single oncology centre experience. Transfus Med 2010; 20(3): 160-168.
11. Massey E, Paulus U, Doree C et al. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2009; (1): CD005341.
12. van de Wetering MD, Weggelaar N, Offringa M et al. Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer 2007; 43(14): 2082-2092.
13. Stanworth SJ, Massey E, Hyde C et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2005; (3): CD005339.
14. Bielorai B, Toren A, Wolach B et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 26(9): 1025-1028.
15. Dinser R, Grgic A, Kim YJ et al. Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft. Eur J Haematol 2005; 74(5): 438-441.
16. Grigull L, Beilken A, Schmid H et al. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer 2006; 14(7): 783-786.
17. Dignani MC, Anaissie EJ, Hester JP et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997; 11(10): 1621-1630.
18. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46(12): 1813-1821.
19. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32(3): 358-366.
20. Pagano L, Caira M, Nosari A et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study- Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45(9): 1161-1170.
21. Cornely OA, Maertens J, Winston DJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356 (4): 348-359.
22. Oza A, Hallemeier C, Goodnough L et al. Granulocyte-colony-stimulating factormobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion 2006; 46(1): 14-23.
23. Samadi DS, Goldberg AN, Orlandi RR. Granulocyte transfusion in the management of fulminant invasive fungal rhinosinusitis. Am J Rhinol 2001; 15 (4): 263-265.
24. Seidel MG, Peters C, Wacker A et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 2008; 42(10): 679-684.
25. McCullough J, Weiblen BJ, Clay ME et al. Effect of leukocyte antibodies on the fate in vivo of indium-111-labeled granulocytes. Blood 1981; 58(1): 164-170.
26. Dutcher JP, Schiffer CA, Johnston GS et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983; 62(2): 354-360.
27. Dutcher JP, Riggs C, Jr, Fox JJ et al. Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes. Am J Hematol 1990; 33(4): 238-243.
28. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 2003; 43(12): 1683-1686.
29. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136(6): 788-799.
30. Lin Y, Kanani N, Naughton F et al. Case report: transfusion-related acute lung injury (TRALI)-a clear and present danger. Can J Anaesth 2007; 54(12): 1011-1016.
31. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusionrelated acute lung injury. Transfus Med Rev 2009; 23(4): 266-283.
32. Heim KF, Fleisher TA, Stroncek DF et al. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion 2011; 51(6): 1154-1162.
33. Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis 1997; 12(2): 74-81.
34. McCullough J. Alloimmunization and granulocyte transfusion: a new study confirms old lessons. Transfusion 2011; 51(6): 1128-1131.
35. Dana BW, Durie BG, White RF et al. Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood 1981; 57(1): 90-94.
36. Solal-Celigny P, Meyohas MC. Complement, granulocytes and pulmonary capillaries. Rev Fr Mal Respir 1983; 11(5): 751-767.
37. Bowden RA. Transfusion-transmitted cytomegalovirus infection. Hematol Oncol Clin North Am 1995; 9(1): 155-166.
38. Narvios A, Pena E, Han XY et al. Cytomegalovirus infection in cancer patients receiving granulocyte transfusions. Blood 2002; 99(1): 390-391.
39. Chemaly RF, Torres HA, Hachem R et al. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica 2008; 93(1): 157-158.